A number of other brokerages have also weighed in on AV. Royal Bank of Canada reissued an outperform rating and issued a GBX 540 ($7.46) price objective on shares of Aviva in a report on Wednesday, January 17th. Citigroup restated a buy rating and issued a GBX 603 ($8.33) target price on shares of Aviva in a research note on Tuesday, January 9th. Shore Capital restated a hold rating on shares of Aviva in a research note on Thursday, November 30th. Morgan Stanley restated an overweight rating and issued a GBX 627 ($8.66) target price (down previously from GBX 670 ($9.26)) on shares of Aviva in a research note on Friday, November 3rd. Finally, Deutsche Bank upped their target price on Aviva from GBX 585 ($8.08) to GBX 600 ($8.29) and gave the stock a buy rating in a research note on Monday, December 4th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have assigned a buy rating to the company. Aviva has an average rating of Buy and a consensus price target of GBX 570.53 ($7.88).
Shares of Aviva (LON:AV) traded down GBX 1.40 ($0.02) during mid-day trading on Wednesday, hitting GBX 504.20 ($6.97). The stock had a trading volume of 2,880,000 shares, compared to its average volume of 8,430,000. The firm has a market capitalization of $20,230.00 and a price-to-earnings ratio of 1,867.41. Aviva has a fifty-two week low of GBX 482.20 ($6.66) and a fifty-two week high of GBX 570.50 ($7.88).
Aviva plc is a holding company. The Company provides customers with long-term insurance and savings, general and health insurance, and fund management products and services. Its segments include United Kingdom & Ireland; France; Poland; Italy, Spain and Other; Canada; Asia; Aviva Investors, and Other Group activities.
Receive News & Ratings for Aviva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aviva and related companies with MarketBeat.com's FREE daily email newsletter.